Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID ‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis

2 Nov 2022

Abstract excerpt

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on the healthcare system, economy, and society. Studies have reported that COVID-19 may cause various neurologic symptoms, including cognitive impairment. We aimed to assess the causal effect of COVID-19 on neurodegenerative diseases using two-sample Mendelian randomization (MR) study. METHODS: Genetic variants were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Long-Term Effects of COVID-19
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36321943
DOI: 10.1002/acn3.51688

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID ‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosisPMID 36321943Read ↗

COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization studySemantic proximity Read ↗

Association between Alzheimer’s disease and COVID-19: A bidirectional Mendelian randomizationSemantic proximity Read ↗

Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study.Semantic proximity Read ↗

Association of COVID-19 with Risk and Progression of Alzheimer's Disease: Non-Overlapping Two-Sample Mendelian Randomization Analysis of 2.6 Million Subjects.Semantic proximity Read ↗

COVID-19 in Relation to Alzheimer's Disease: Mendelian Randomization Analyses Add to Multiple Lines of Evidence.Semantic proximity Read ↗

Shared genetics and causal associations between COVID-19 and multiple sclerosis.Semantic proximity Read ↗

Shared Genetic Architecture Between COVID-19 Severity and Alzheimer's Disease Across European and African AncestriesSemantic proximity Read ↗

Shared Genetic Architecture Between COVID-19 Severity and Alzheimer's Disease Across European and African AncestriesSemantic proximity Read ↗

Causal relationship of COVID-19 on Alzheimer’s disease: an updated Mendelian randomization studySemantic proximity Read ↗

Causal associations of COVID-19 with health and disease outcomes: a systematic review and meta-analysisSemantic proximity Read ↗

Causal associations and genetic overlap between COVID-19 and intelligence.Semantic proximity Read ↗

Intersection of COVID-19 and Alzheimer's Disease: Genetic Insights and Neuropathological Consequences.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.